HAGH抗体;HAGH Antibody—艾普蒂

+ +

•  

   

     Western blot analysis using HAGH mouse mAb against  rat liver tissue lysate    

  
  

The HAGH (Hydroxyacylglutathione Hydrolase) antibody is a tool used to study the HAGH enzyme, also known as glyoxalase II (GLO2), a critical component of the glyoxalase system. This system detoxifies methylglyoxal (MG), a reactive byproduct of glycolysis linked to cellular damage, aging, and pathologies like diabetes, neurodegenerative diseases, and cancer. HAGH catalyzes the hydrolysis of S-D-lactoylglutathione to D-lactate and glutathione, completing the conversion of MG into harmless metabolites.

Research on HAGH antibodies focuses on understanding the enzyme's expression, localization, and role in disease. Studies suggest HAGH dysregulation may contribute to oxidative stress-related conditions, cancer progression, and diabetic complications. Antibodies against HAGH enable detection via techniques like Western blotting, immunohistochemistry, and ELISA, aiding in profiling its tissue distribution and quantifying levels in clinical samples.

Structurally, HAGH is a zinc-dependent metalloenzyme encoded by the HAGH gene on human chromosome 16. Its activity is influenced by genetic polymorphisms and post-translational modifications. Recent interest explores HAGH as a potential therapeutic target or biomarker, particularly in cancers where MG accumulation promotes genomic instability. However, its dual role in cytoprotection and metabolic signaling requires further investigation. HAGH antibodies thus serve as vital reagents in elucidating its pathophysiological mechanisms and therapeutic potential.